These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1329443)

  • 21. Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide--I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs.
    Dietrich FM; Hochkeppel HK; Lukas B
    Int J Immunopharmacol; 1986; 8(8):931-42. PubMed ID: 2433236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
    Akasaki M; Takashi T; Kita Y; Tsukada W
    Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
    Azuma I
    Int J Immunopharmacol; 1992 Apr; 14(3):487-96. PubMed ID: 1618600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
    Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
    Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the synthetic lipid A-related compound, DT-5461, on resistance to Sendai virus infection in mice.
    Yoshida R; Sato K; Yoo YC; Yoshimatsu K; Tamura M; Ishihara C; Arikawa J; Azuma I
    Immunopharmacology; 1994; 28(2):153-61. PubMed ID: 8002289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenicity study of muroctasin.
    Yamaguchi F; Hattori H; Wagai N; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
    Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I
    Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs.
    Ikeda S; Negishi T; Nishimura C
    Antiviral Res; 1985 Aug; 5(4):207-15. PubMed ID: 2412489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyl dipeptide, against malignant pleurisy associated with lung cancer.
    Yanagawa H; Haku T; Takeuchi E; Suzuki Y; Nokihara H; Sone S
    Lung Cancer; 2000 Feb; 27(2):67-73. PubMed ID: 10688489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
    Yamaguchi F; Akasaki M; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of plasma fibronectin production in mice by muroctasin.
    Endo N; Okuda T; Osada Y; Zen-Yoji H
    Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
    Ishihara C; Yamamoto K; Hamada N; Azuma I
    Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced resistance to Sendai virus infection in DBA/2J mice with a botanical drug combination (Sinupret).
    Schmolz M; Ottendorfer D; März RW; Sieder C
    Int Immunopharmacol; 2001 Sep; 1(9-10):1841-8. PubMed ID: 11562075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.